{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-034766","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2024-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.054284+00:00","generated_at":"2026-05-31T13:03:28.844942+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Esperion CMO JoAnne Foody to depart by Sept 16; transition to Senior Advisor effective Aug 5","bullets":["JoAnne Foody steps down as CMO effective Aug 5; remains as Senior Advisor until Sep 16.","Severance includes 12 months salary, health coverage, prorated FY2024 bonus, extended option exercise.","Transition Agreement signed Aug 3; Foody to cooperate as Senior Advisor on requested basis.","No successor named; search for new CMO presumably underway."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-034766","json":"https://secwatch.observer/filing/0001628280-24-034766.json","markdown":"https://secwatch.observer/filing/0001628280-24-034766.md","text":"https://secwatch.observer/filing/0001628280-24-034766.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024034766/0001628280-24-034766-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024034766/espr-20240803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:03:28.844942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5cd638a962","claim":"JoAnne Foody changed role as Chief Medical Officer at Esperion Therapeutics, Inc..","evidence_excerpt":"JoAnne Foody will be transitioning from her role as the Company’s Chief Medical Officer and that her employment with the Company will end on or before September 16, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024034766/0001628280-24-034766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioning"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}